Our study underlines strong interactions between class IIa HDAC9 and ERα signaling (Fig. 5) and undercovers the key role of HDAC9 in antiestrogen resistance of breast cancer cells and tumors. This evidence concerns the gene ESR1 and breast carcinoma.